Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Highly Stringent Split Intein-Mediated DHFR Selectable Marker Enables Efficient Development of High-Producing CHO Cells for Therapeutic Proteins.

ACS synthetic biology·2026
Same author

Identifying policy-relevant traffic crash risk factors in Cheongju, South Korea using logistic regression and explainable machine learning.

PloS one·2026
Same author

Multivariate analysis of the effects of high seeding density on therapeutic protein production and sialylation in an intensified CHO cell culture process.

Bioprocess and biosystems engineering·2026
Same author

Impact of online gambling on youth problem behaviors during COVID-19 periods in South Korea.

Scientific reports·2026
Same author

Chemicals Affecting Autophagy in rCHO Cell Cultures and Their Impacts on Therapeutic Protein Production Processes.

Journal of microbiology and biotechnology·2026
Same author

Comparative Evaluation of YOLOv8 and YOLOv11 for Digital Phenotyping of Edible Mushrooms Under Controlled Cultivation Conditions.

Journal of fungi (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 27, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.2K

SiMPl-GS: Advancing Cell Line Development via Synthetic Selection Marker for Next-Generation Biopharmaceutical

Chansik Yoon1, Eun-Ji Lee2,3, Dongil Kim1

  • 1Department of Biological Sciences, KAIST, Daejeon, 34141, Republic of Korea.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|August 6, 2024
PubMed
Summary

A new synthetic selection system, SiMPl-GS, improves cell line development for therapeutic proteins. This system enhances selection efficiency and enables simultaneous selection of multiple genes, accelerating drug discovery.

Keywords:
Chinese hamster ovary cellsantibody productioncell line developmentglutamine synthaseselection markersplit intein, synthetic biology

More Related Videos

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.5K
Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
10:28

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

8.9K

Related Experiment Videos

Last Updated: Jun 27, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.2K
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.5K
Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
10:28

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

8.9K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cell Biology

Background:

  • Efficient cell line development (CLD) is crucial for rapid therapeutic protein production.
  • Current glutamine-based selection systems face limitations in efficiency, stringency, and multiplexing capabilities.

Purpose of the Study:

  • To design and validate a novel AND-gate synthetic selection system for enhanced CLD.
  • To improve the efficiency and stringency of gene selection in cell line development.

Main Methods:

  • Rational design of a synthetic selection system using split intein-mediated protein ligation of glutamine synthetase (SiMPl-GS).
  • Computational identification and experimental validation of GS split sites in GS-knockout Chinese hamster ovary cells.
  • Evaluation of SiMPl-GS performance in CLD compared to wild-type GS.

Main Results:

  • SiMPl-GS demonstrated superior performance over wild-type GS in cell line development.
  • The system selectively enriched high-producing cell pools, with most cells producing high levels of therapeutic proteins.
  • Orthogonal split intein pairs enabled single-step selection of four plasmids, streamlining the development of multispecific antibody-producing cell lines.

Conclusions:

  • SiMPl-GS offers a simple and effective method to accelerate cell line development for therapeutic protein production.
  • The synthetic selection system overcomes limitations of traditional methods, improving efficiency and multiplexing.
  • This approach is particularly beneficial for developing complex biologics like multispecific antibodies.